Krystal Biotech, Inc. (KRYS)
250.08
-1.60
(-0.64%)
USD |
NASDAQ |
Mar 23, 16:00
250.15
+0.07
(+0.03%)
After-Hours: 20:00
Krystal Biotech Total Liabilities (Quarterly) : 114.23M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 675.63M |
| Scholar Rock Holding Corp. | 158.78M |
| Alkermes Plc | 710.96M |
| Stoke Therapeutics, Inc. | 65.98M |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.334B |
| Shareholders Equity (Quarterly) | 1.220B |
| Debt to Equity Ratio | 0.0077 |
| Current Ratio | 9.953 |
| Net Debt Paydown Yield | -0.01% |